Targeting Olokizumab-Interleukin 6 interaction interface to discover novel IL-6 inhibitors
Description
The IL-6/IL-6R or IL-6/GP130 protein-protein interactions play a significant role in controlling the development of chronic inflammatory diseases, such as rheumatoid arthritis, Castleman disease, psoriasis, and, most recently, COVID-19. Modulating or
